Invention Grant
US09301942B2 Use of icaritin for the preparation of composition for treating cancer
有权
使用icaritin制备治疗癌症的组合物
- Patent Title: Use of icaritin for the preparation of composition for treating cancer
- Patent Title (中): 使用icaritin制备治疗癌症的组合物
-
Application No.: US14291639Application Date: 2014-05-30
-
Publication No.: US09301942B2Publication Date: 2016-04-05
- Inventor: Kun Meng , Hongxia Ding , Shu Li , Ya Tuo , Yueqiu Shen
- Applicant: BEIJING SHENOGEN PHARMA GROUP LTD.
- Applicant Address: CN Beijing
- Assignee: BEIJING SHENOGEN PHARMA GROUP LTD.
- Current Assignee: BEIJING SHENOGEN PHARMA GROUP LTD.
- Current Assignee Address: CN Beijing
- Agency: Scully, Scott, Murphy & Presser, P.C.
- Priority: CN201310210669 20130531
- Main IPC: A61K31/352
- IPC: A61K31/352
Abstract:
The present invention provides the use of Icaritin for the preparation of a composition for treating cancer, wherein the composition is orally administered to a patient at least one cycle, each cycle comprising a continuous 28-day dosing schedule, in which Icaritin is administered at least once daily, at a dosage of 400-1800 mg daily. The patients treated with Icaritin according to the present method receive better treatment, with reduced adverse effects.
Public/Granted literature
- US20140357876A1 USE OF ICARITIN FOR THE PREPARATION OF COMPOSITION FOR TREATING CANCER Public/Granted day:2014-12-04
Information query
